BNET Industries
Last Fiscal Year Sales:$35.9B
- Public
- DE
Dow Jones Description
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and improved earning power. We already successfully reorganized the Bayer Group and further streamlined our portfolio to create a new Bayer that is focused on its corporate strengths, its customers and the markets of the future. To help us achieve this goal, we then carried out a strategic realignment in order to concentrate in future on three high-potential, agile subgroups with largely independent operations: HealthCare, CropScience and MaterialScience, supported by three service companies. Our operating companies give us the access we need to the growth markets of the future. As an inventor company, we plan to continue setting trends in research-intensive areas. Innovations are the foundation for our competitiveness and our corporate growth, and thus for our success in the future. We believe our technical and commercial expertise entails a duty to contribute to sustainable development ? a principle we wholeheartedly endorse, mindful of its social, ethical and environmental elements. In awareness of our responsibilities as a corporate citizen, we define economy, ecology and social commitment as objectives of equal rank. We seek to retain society?s confidence through performance, flexibility and open communication as we work in pursuit of our overriding corporate goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
Director, Finance
Klaus KuhnNumber of Employees 122,100
Peer Companies
NAICS Code Plastics Material and Resin Manufacturing: 325211
Recent Events
-
Bayer guilty; $2M to local farmers
-
Endo Pharma Gets a Setback
-
Bayers Betaferon approved in China for Treatment of Multiple Sclerosis
-
UPDATE 3-US FDA declines to approve Endo testosterone drug
-
UPDATE 1-Futuragene signs licence deal with Bayer CropScience
-
Bayer and United Nations Environment Programme Launch 19th Annual International Children's...
-
Bayer Consumer Care Launches CitracalR Calcium Plus Heart Health
-
German drug, chemical company Bayer's Q3 net income falls 10 per cent
-
Bayer, US Onyx launch phase III trial of Nexavar in patients with non-responsive thyroid cancer
-
BRIEF-Credit Suisse raises targets on European pharma cos
-
Bayer accused of hiding Yaz contraceptive risk
-
Bayer downgraded to neutral from buy at UBS
-
Abbott Laboratories to acquire Solvay Pharmaceuticals
-
Bayer's contested kidney cancer drug shows benefit
-
Bayer names new CEO
-
Bayer's next CEO has a year to prepare Today
News & Analysis
Filter by
aventis and bayer ag - All News and Analysis
CLS emerges as a new suitor for Aventis blood plasma unit. (News).(Brief Article)
- 2003-02-24
JUST WEEKS after a deal with Bayer fell apart, Aventis announced last week that it has found another suitor for Aventis Behring, its therapeutic proteins business. The company says it is in preliminary discussions with the Australian biopharmaceuti JUST WEEKS after a deal with...
Global blood pressure for CSL.
- 2002-11-11
Nov 10, 2002 (The Age - ABIX via COMTEX) Australian blood and plasma company, CSL, has been one of the worst performers since the start of 2002. The company's shares, which were trading above the $A50 mark, have fallen by two-thirds to close at ...
CSL bid for world niche is touch and go.
- 2002-11-11
Nov 10, 2002 (The Sydney Morning Herald - ABIX via COMTEX) Australian blood and plasma company, CSL, has been one of the worst performers since the start of 2002. The company's shares, which were trading above the $A50 mark, have fallen by two-thirds to close...
BASF buys bayer insecticides and seed treatment for [euro]1.2Bn. (News: Europe).(Bayer AG sells Fipronil and several fungicides)
- 2002-11-04
BASF HAS AGREED to buy from Bayer the insecticide Fipronil and several fungicides for seed treatment. Those were originally owned by Aventis before Bayer took over that company's crop protection business last year. The total package of produc ...
Bayer continues integration with Aventis.
- 2002-07-24
Argentina, Jul 19, 2002 Argentina, Jul 19, 2002
It's final: Bayer buys Aventis CropScience. (Industry Almanac: news you can use).(Brief Article)
- 2002-07-01
MONTVALE, NJ, AND KANSAS CITY, MO -- Bayer CropScience, Monheim, Germany, has been formed by Bayer AG's acquisition of Aventis CropScience. The new company is divided into three business groups: Crop Protection, Bio Science and Environmental Scienc MONTVALE, NJ, AND KANSAS CITY, MO --...
BASF considers agro acquisitions. (News).(including agrochemical business of Bayer CropScience)(Brief Article)
- 2002-06-24
BASF AG PLANS to make four acquisitions worth a total of [epsilon]2.5 billion ($2.4 billion), Max Dietrich Kley, the company's finance director, said in an interview with a German magazine. He did not, however, reveal any more details about the ta BASF AG...
Bayer lowers forecast for CropScience business. (News: Europe).(sales, profit forecast)(Brief Article)(Statistical Data Included)
- 2002-06-10
BAYER CROPSCIENCE, formed last week through Bayer AG's [euro]7.25 billion ($6.8 billion) acquisition of Aventis CropScience, has lowered its sales and profit forecast for the new business. Bayer had predicted that by 2005, the merged business, BAYER CROPSCIENCE, formed...
Bayer Acquisition of Aventis CropScience Finalized; Bayer Environmental Science, North America to Serve Professional and Consumer Specialty Markets
- 2002-06-05
Business Editors
Bayer gets FTC green light. (Breaking News Roundup).(Federal Trade Commission approves Aventis Crop Science acquisition)(Brief Article)
- 2002-06-03
The Federal Trade Commission FTC has approved Bayer AG's acquisition of Aventis Crop Science subject to the divestment and outlicensing of certain products. The European Commission approved the deal last month, To consummate the deal, FTC says Ba The Federal Trade Commission FTC has...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Klaus Kuhn | Director, Finance |
| Richard Pott | Director, Strategy and Human Resources |
| Wolfgang Plischke | Director, Innovation, Technology and Environment |
| Hartmut Klusik | Head, Product Supply |
| Gary S Balkema | Executive Committee Member |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Arthur J Higgins | Chairman, HealthCare |
| Werner Wenning | Executive Chairman |
| Klaus Kleinfeld | Board of Directors |
| Paul Achleitner | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Finance | Current |
| University of South Carolina | MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Strategy and Human Resources | Current |
| University of Cologne | doctorate in physics | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Director, Innovation, Technology and Environment | Current |
| Bayer HealthCare AG | Manager | Current |
| Bayer HealthCare AG | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Head, Product Supply | Current |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Chairman, HealthCare | Current |
| Enzon Pharmaceuticals, Inc. | CEO | Former |
| Pharmaceutical Research and Manufacturers of America | member | Former |
| Bayer HealthCare, Animal Health Division | Chairman | Former |
| Enzon Pharmaceuticals, Inc. | Chairman | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Chairman | Current |
| Henkel AG & Co. KGaA | Supervisory Board | Current |
Klaus Kleinfeld is president and chief executive officer of Alcoa. He joined the company in 2007 as president and chief operating officer and seven months later assumed CEO responsibilities. He has served on Alcoa's board of directors since 2003. Alcoa is a world leader in the production and management of a very sustainable product: aluminum. Nearly 75% of the aluminum ever produced since 1888 is still in use today. The company has been a technology leader since its beginning, providing more than 90% of the aluminum alloys used in aircraft and space flight; helping making automobiles lighter, without compromising safety or performance; manufacturing sheet that created the ultimate recyclable container, the aluminum beverage can; and providing building and construction industry materials that help further the green building movement. In addition, to serving customers in these markets, Alcoa also markets wheels, fastening systems, precision and investment castings, and building systems. The company has 97,000 employees in 34 countries. Before coming to Alcoa, Mr. Kleinfeld had a 20-year career with Siemens, the global electronics and industrial conglomerate, based in the U.S. and Germany, where he served as chief executive officer of Siemens AG starting in 2005. During his tenure, Mr. Kleinfeld presided over a dramatic transformation of the company, reshaping the company's portfolio around three high growth areas, resulting in increase of revenues and market capitalization nearly doubled. Prior to his service on the Managing Board of Siemens AG, Mr. Kleinfeld was President and Chief Executive Officer of Siemens Corporation, its U.S. arm and the company's largest region. In addition to serving on Alcoa's board, he is a member of the board of Bayer AG. On the personal front, Mr. Kleinfeld was born in Bremen, Germany and educated at the University of Goettingen and University of Wuerzburg, both in Germany. He holds a Ph.D in strategic management and master's degree in business administration. In his leisure time, he enjoys skiing, tennis, the arts and is a marathon runner. Mr. Kleinfeld resides in New York with his wife and children.
| Organization | Position | Status |
|---|---|---|
| Alcoa, Inc. | President & Chief Executive Officer | Current |
| Bayer AG | Board of Directors | Current |
| Alcoa, Inc. | Board of Directors | Current |
| Siemens AG | President & CEO | Former |
| Siemens Corporation | Chief Executive Officer | Former |
| Alcoa, Inc. | Chief Operating Officer | Former |
| Siemens Corporation | Chief Operating Officer | Former |
| Siemens AG | Chief Operations Officer, U.S. | Former |
| Siemens AG | Executive Vice President | Former |
| Siemens AG | Audit Committee Principal | Former |
| Citigroup Inc. | Board of Directors | Former |
| Siemens AG | Board of Directors | Former |
| Siemens Corporation | member | Former |
| Organization | Position | Status |
|---|---|---|
| Allianz SE | Executive Director, Finance | Current |
| Bayer AG | Board of Directors | Current |
| Goldman, Sachs & Co. | Vice President, Mergers & Acquisitions | Former |
| Bain & Company | Manager, Strategy Consulting | Former |
| Organization | Position | Status |
|---|---|---|
| Bayer AG | Executive Committee Member | Current |
| Bayer HealthCare, Animal Health Division | President, Worldwide Bayer Consumer Care Division | Former |
| Fairleigh Dickinson University | master of business administration degree | Former |
Executive News
-
Report from Europe: U.S. Close vs. China Rebound
-
Alcoa Named Component of Dow Jones Sustainability Index for Eighth Consecutive Year
-
Alcoa says global aluminium demand to fall 5.5 pct -Bloomberg
-
Siemens To Settle Bribery Charges with Three Former Execs
-
Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
UPDATE 1-Siemens poised to settle with ex-managers
-
Bayer AG (BAY.F) May Be Ready for Deals After Lost Intervet Bid
-
Inventories May Temper Aluminum Rally
Industry Transcripts by Seeking Alpha
-
Steelcase Incorporated Q3 2010 Earnings Call Transcript
on Dec 18, 2009about SCS
-
Quiksilver Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 17, 2009about ZQK
-
NIKE, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about NKE
-
Actuant Corp. F1Q10 (Qtr End 11/30/2009) Earnings Call Transcript
on Dec 17, 2009about ATU
-
Apogee Enterprises F3Q10 (Qtr End 11/28/09) Earnings Conference Call Transcript
on Dec 17, 2009about APOG
Glass Door
Bayer AG
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Newspapers Will Survive Only If They Remember Why They Exist 6 votes
Presented by American Express